Industries > Pharma > Pre-Filled Syringes Market Report 2023-2033
Back to Pharma Reports
Pre-Filled Syringes Market Report 2023-2033

Pre-Filled Syringes Market Report 2023-2033

Forecasts by Type (Conventional, Safety), by Material (Glass, Plastic, Stainless Steel, Elastomer), by Design (Single Chambered, Dual Chambered, Customised), by Delivery (Intravenous, Subcutaneous, Intramuscular, Others), by Application (Vaccines, Thrombosis, Diabetes, Anaphylaxis, Ophthalmology, Cancer, Others), by Molecule (Large Molecules, Small Molecules), by End-user (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharma & Biotech Companies, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 24 February 2023
PAGES: 376
PRODUCT CODE: PHA1234
SUBMARKET: Medical Devices

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1234 Categories: , Tags: ,

The Pre-Filled Syringes Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Innovation to Meet the Growing Demand for Pre-Filled Syringes
Pre-Filled syringes continue to advance in order to improve workflow, facilitate more automation at the fill/finish line, and increase output. Innovations in syringe design also improve patient and caregiver safety, boost productivity, and cut down on product and packaging waste. As the pre-filled syringes are fully packaged and ready to administer it prevents unnecessary handling before the actual application and saves time. It also lessens non-sterility concerns, medication errors and dilution problems.

Supplier innovations emphasize the convenience of pre-filled syringes and concentrate on expanding size options (especially for larger quantities), reducing waste, and improving patient and caregiver safety. For example: Gerresheimer’s product line for sensitive large molecules (biologics, biosimilars and biobetters) have added Gx RTF ClearJect COP needle syringe and 1.0-mL luer lock. Line expansions at West Pharmaceutical Services include insert needle syringes (the plastic equivalent of a staked needle glass syringe) as well as more options for needle sizes and product volumes.

Difficulty in Sterilization and Availability of Cheaper Alternatives
Medical device makers do not have the same issues as pharmaceutical companies because their products are typically made of plastics, metals, or other materials that are easily sterilised. However, because pre-filled syringes are considered a combination product, the issues that pre-filled syringes confront in sterilising are distinct from those that medical device producers encounter. Autoclaving or ionising radiation are the most common ways to sterilise pre-filled syringes. The gadget is usually heated in a steam autoclave before being sterilised. Steam sterilisation, on the other hand, is time-consuming and labour-intensive, and also degrades product aesthetics due to package degradation caused by the steam treatment.

Moreover, the availability of less expensive alternatives to pre-filled syringes, as well as a focus on developing alternative drug administration techniques, may limit the market throughout the forecast period. Because pre-filled syringes are costly due to a difficult manufacturing process, patients may choose for less expensive medication administration methods such as needle-free injectors, which stifles market growth. Furthermore, a high incidence of needle stick injuries is linked to the use of naked pre-filled syringes, as patients are unaware that they can use the pre-filled syringes without medical help, potentially harming themselves.

What Questions Should You Ask before Buying a Market Research Report?
• How is the pre-filled syringes market evolving?
• What is driving and restraining the pre-filled syringes market?
• How will each pre-filled syringes submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each pre-filled syringes submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading pre-filled syringes markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pre-filled syringes projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of pre-filled syringes projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pre-filled syringes market?
• Where is the pre-filled syringes market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the pre-filled syringes market today, and over the next 10 years:
• Our 376-page report provides 161 tables, 252 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the pre-filled syringes market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
• Conventional
• Safety

Material
• Glass
• Plastic
• Elastomer
• Stainless Steel

Design
• Single Chambered
• Dual Chambered
• Customised

Delivery
• Intravenous
• Subcutaneous
• Intramuscular
• Others

Application
• Vaccines
• Thrombosis
• Diabetes
• Anaphylaxis
• Ophthalmology
• Cancer
• Others

Molecule
• Large Molecule and
• Small Molecule

End User
• Hospital & Clinics,
• Homecare Settings,
• Research Laboratories,
• Pharma & Biotech Companies and
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA
• GCC
• South Africa
• Turkey
• Rest of MEA

Pre-Filled Syringes Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Pre-Filled Syringes Market 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• AptarGroup, Inc.
• Baxter
• BD (Becton Dickinson and Company)
• Biocon
• Cardinal Health
• Catalent Inc.
• Datwyler Holding Inc.
• Elcam Medical
• Fresenius SE & Co. KGaA
• Gerresheimer AG
• Haselmeier
• Jiangsu Micsafe Medical Technology Co., Ltd
• MedXL Inc.
• Nipro Medical Corporation
• Owen Mumford
• Schott
• Terumo Corporation
• West Pharmaceutical Services, Inc.
• Ypsomed AG

Overall world revenue for Pre-Filled Syringes Market, 2023 to 2033 in terms of value the market will surpass US$4,247.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pre-Filled Syringes Market, 2023 to 2033 report help you?
In summary, our 370+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Pre-Filled Syringes Market, 2023 to 2033 Market, with forecasts for type, material, design, application, molecule and end user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Pre-Filled Syringes Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 19 of the major companies involved in the Pre-Filled Syringes Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pre-Filled Syringes Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pre-Filled Syringes Market Report 2023-2033: Forecasts by Type (Conventional, Safety), by Material (Glass, Plastic, Stainless Steel, Elastomer), by Design (Single Chambered, Dual Chambered, Customised), by Delivery (Intravenous, Subcutaneous, Intramuscular, Others), by Application (Vaccines, Thrombosis, Diabetes, Anaphylaxis, Ophthalmology, Cancer, Others), by Molecule (Large Molecules, Small Molecules), by End-user (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharma & Biotech Companies, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pre-Filled Syringes Market Report 2023-2033

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Pre-Filled Syringes Market Report 2023-2033

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ
      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ
      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ